FIELD: medicine.
SUBSTANCE: peptide of the following formula: X-Pro-Gly-P, where X = Thr-Lys-Pro-Arg-; Lys-pro-Arg-; pro-Arg-; Arg-, being of untiulcerous activity. They should be applied at intraperitoneal injection at the dosage of 0.58-3.20 mcM g/kg for preventing and treating ulcers of gastro-intestinal tract.
EFFECT: higher efficiency and prophylaxis.
4 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING AND TREATING GASTRIC ULCERS IN ANIMALS | 2002 |
|
RU2217158C1 |
| AGENT FOR PROPHYLAXIS AND TREATMENT OF GASTROENTERIC TRACT ULCERS, METHOD OF TREATMENT AND METHOD OF PROPHYLAXIS OF GASTROENTERIC TRACT ULCERS | 2001 |
|
RU2191593C1 |
| ADMINISTRATION OF Pro-Gly-Pro PEPTIDE AS INTRANASAL AGENT IN PREVENTION AND TREATMENT OF GASTRIC ULCER IN RATS | 2009 |
|
RU2414923C1 |
| APPLICATION OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE (SELANK) FOR HEPATOPROTECTIVE IMPACT IN CHRONIC EMOTIONAL-PAIN STRESS | 2016 |
|
RU2629832C1 |
| APPLICATION OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANG) FOR DYSBIOSIS CORRECTION UNDER CHRONIC IMMOBILIZATION STRESS | 2018 |
|
RU2681217C1 |
| USE OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANC) HEPATOPROTECTIVE FOR EXPOSURE IN ACUTE IMMOBILISATION STRESS | 2015 |
|
RU2582963C1 |
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
| PHARMACOLOGICAL AGENT FOR THE TREATMENT OF GASTRIC ULCER | 2018 |
|
RU2688187C1 |
| MOTILIN-LIKE PEPTIDE COMPOUND HAVING IMPARTED TRANSMUCOSAL ABSORBING ABILITY | 2010 |
|
RU2540012C2 |
| APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
